Learn more about our diagnostic instruments and assays and how we’re supporting the U.S. Government.
From completely waterless, high-throughput chemistry systems that go anywhere to comprehensive assay menus for infectious disease, chronic disease management, metabolic testing and more, QuidelOrtho offers a range of solutions to meet the unique testing needs of U.S. Government – from home to hospital, lab to clinic.
Company profile
Nasdaq Stock Exchange: QDEL
Footprint: 140+ countries
Number of teammates: ~6,700+
Revenue: $2.73B (2025)
A responsive, reliable partner to the U.S. Government
In March 2020, shortly after the first COVID-19 patient was diagnosed in the U.S., QuidelOrtho’s Chief Executive Officer was invited to meet with the newly formed White House Coronavirus Task Force to discuss testing. Two weeks later, the company began shipping its first emergency-use-authorized Lyra™ Tests for COVID-19. On May 8, 2020, QuidelOrtho introduced a test compatible with the SOFIA™ and SOFIA 2 analyzers – the first-ever 15-minute rapid antigen test to detect COVID-19.
Committed to meeting the needs of the U.S. Government
In just two years, the company partnered with the National Institutes of Health’s Acceleration of Diagnostics to expand SOFIA test manufacturing from 84 million test cassettes per year to more than 220 million cassettes per year. In 2021, the company received emergency use authorization (EUA) for its QUICKVUE™ At-Home OTC COVID-19 Test and quickly opened a 128,000-square-foot facility with the capacity to manufacture the COVID-19 tests that tens of millions of Americans relied on during the pandemic.
VITROS™ Systems innovative waterless laboratory solutions for uninterrupted operation in any challenging terrain or location
VITROS Systems and Assays use zero water, eliminating the need for municipal resources while encouraging conservation.
Because VITROS Systems do not use water, there’s no waste or potentially toxic materials to enter local drainage.
Eliminate risk of erroneous results from water contamination, plus single-use consumables that eliminate carryover.
With no need for water, VITROS Systems do not require plumbing or drains and can operate anywhere your lab is needed.
VIRENA™ System – surveillance and mapping for respiratory season
VIRENA System is a wireless, cloud-based data management and surveillance system to help public health officials stay prepared for respiratory season. Designed for healthcare providers and clinical labs, VIRENA System automatically collects, manages and analyzes de-identified test results from select QuidelOrtho point-of-care testing platforms.
Our offerings
All QuidelOrtho products are backed by our award-winning customer experience. Year after year, QuidelOrtho is consistently recognized for industry-leading excellence in customer experience, service and support. It starts with reliable, high-performing systems that keep customers powered up and ready, complemented by responsive support and service where and when you need it. It's why 98% of the time, customers stay with us for an average of +10 years.
Customer Experience Program
Award-winning evolution of how service, expertise, technology and data-driven solutions come together to create a more effective, efficient lab so our customers can focus on improving patient outcomes.
Labs
Clinical diagnostic testing systems that deliver fast, accurate, reliable test results for the clinicians and patients who need them.
Flexible and scalable automation solutions for labs of all sizes.
Molecular Diagnostics
Setting a new standard for point-of-care respiratory molecular testing by delivering the fastest RT-PCR influenza + SARS results.
Open platform, high throughput molecular testing solutions that detect and identify infectious diseases with minimal steps.
Simplified platform that uses our proprietary helicase-dependent amplification (HDA) with fluorescence detection to make diagnosing infectious diseases faster and easier than before.
Point of Care
A family of rapid, visually read, lateral flow tests to produce accurate results in minutes.
Accurately detects the SARS-CoV-2 Omicron variant (among others).
Small bench-top analyzers that take rapid testing to a new level using proven lateral-flow technology and advanced fluorescence chemistry.
Comprehensive test menu that provides the diagnostic answers needed to assist in making rapid, cost-effective treatment decisions.
Transfusion Medicine
Semi-automated pre-transfusion card reader designed to automate reaction grading and elevate labs’ performance to higher levels.
Automated pretransfusion testing platform that automates over 99% of workload in the blood bank without compromising turnaround time.
Paired with the ORTHO OPTIX™ Reader, provides a complete semi-automated testing platform, with combined incubation and centrifugation to provide an even smaller footprint in the lab.
QuidelOrtho understands and values the role small businesses play in our communities. Today, the company does business with more than 600 small businesses across the U.S., including several that are U.S. government–certified small and disadvantaged companies.
Certified Small and Disadvantaged Business Partners
- Cenmed Enterprises
- Hazlow Electronics Inc
- Keystone Environmental
- Pacific Technologies and Solutions
- Tirone Electric Inc
- United Seal and Rubber Co Inc
With more than 550 assays test products available around the world, QuidelOrtho invests heavily in research and development. The company has research relationships with a growing number of universities and colleges.
Learn more about our relationships with the U.S. government or colleges/universities.
